GASCO, Valentina
GASCO, Valentina
SCIENZE MEDICHE
A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life.
2024-01-01 Aversa LS, Cuboni D, Grottoli S, Ghigo E, Gasco V.
Acromegalia e gravidanza: quali rischi per la madre e per il feto
2010-01-01 S. Grottoli, V. Gasco, N. Prencipe, E. Ghigo
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients
2020-01-01 Prencipe N.; Scarati M.; Manetta T.; Berton A.M.; Parisi S.; Bona C.; Parasiliti-Caprino M.; Ditto M.C.; Gasco V.; Fusaro E.; Grottoli S.
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults.
2013-01-01 Gasco V;Beccuti G;Baldini C;Prencipe N;Di Giacomo S;Berton A;Guaraldi F;Tabaro I;Maccario M;Ghigo E;Grottoli S
Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease
2015-01-01 Gasco V;Berton A;Caprino MP;Karamouzis I;Maccario M;Ghigo E;Grottoli S
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects.
2023-01-01 Varaldo E, Bioletto F, Cuboni D, Prencipe N, Bona C, Barale M, Ghigo E, Grottoli S, Berton AM, Gasco V.
An overview of the controversies of adult growth hormone deficiency diagnosis.
2025-01-01 Cuboni D, Aversa LS, Grottoli S, Ghigo E, Gasco V
Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement
2022-01-01 Cannavò S; Cappa M; Ferone D; Isidori AM; Loche S; Salerno M; Maghnie M; Aimaretti G; Ambrosio MR; Bellone S; Caruso M; Castello R; Ceccato F; Cerbone T; Cherubini V; de Carlo E; De Sanctis L; della Casa S; Di Somma C; Faienza MF; Gasco V; Gaudino R; Giacomozzi C; Giavoli C; Guazzarotti L; Klain A; Lania A; Leonardi D; Longhi S; Lughetti L; Maggio MC; Wasniewska GM; Mameli C; Mauro C; Miraglia Del Giudice E; Palermo MCA; Parpagnoli M; Persani L; Pilotta A; Pozzobon G; Rochira V; Rota F; Sacco M; Scarcella S; Scavuzzo F; Sinisi AA; Street ME; Tornese G
Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia?
2024-01-01 Varaldo E, Cuboni D, Prencipe N, Aversa LS, Sibilla M, Bioletto F, Berton AM, Gasco V, Ghigo E, Grottoli S
Association of craniopharyngioma and pituitary adenoma.
2013-01-01 Guaraldi F;Prencipe N;di Giacomo V;Scanarini M;Gasco V;Gardiman MP;Berton AM;Ghigo E;Grottoli S
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study
2021-01-01 Parasiliti Caprino M, Obert C, Lopez C, Bollati M, Bioletto F, Bima C, Egalini F, Berton AM, Prencipe N, Settanni F, Gasco V, Mengozzi G, Ghigo E, Maccario M.
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
2023-01-01 Gasco V, Giannelli J, Campioni L, Arvat E, Ghigo E, Grottoli S, Maccario M, Giordano R.
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment
2021-01-01 Prencipe N.; Bona C.; Cuboni D.; Parasiliti-Caprino M.; Berton A.M.; Fenoglio L.M.; Gasco V.; Ghigo E.; Grottoli S.
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond
2024-01-01 Bioletto, Fabio; Varaldo, Emanuele; Gasco, Valentina; Maccario, Mauro; Arvat, Emanuela; Ghigo, Ezio; Grottoli, Silvia
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM
2006-01-01 A. Picu; R. Giordano ; L. Bonelli; M. Balbo; M. Pellegrino; R. Berardelli; G. Corneli; V. Gasco; A. Gariano; E. Arvat
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
2023-01-01 Berton, Alessandro Maria; Parasiliti-Caprino, Mirko; Prencipe, Nunzia; Bioletto, Fabio; Lopez, Chiara; Bona, Chiara; Caputo, Marina; Rumbolo, Francesca; Ponzetto, Federico; Settanni, Fabio; Gasco, Valentina; Mengozzi, Giulio; Ghigo, Ezio; Grottoli, Silvia; Maccario, Mauro; Benso, Andrea Silvio
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma
2006-01-01 GROTTOLI S; GASCO V; BROGLIO F; BALDELLI R; RAGAZZONI F; GALLENCA F; MAINOLFI A; PRODAM F; MUCCIOLI G; GHIGO E
Cost-of-illness study in acromegalic patients in Italy.
2004-01-01 DIDONI G ;GROTTOLI S ;GASCO V ;BATTISTINI M ;FERONE D ;GIUSTI M ;RAGAZZONI F ;RUFFO P ;GHIGO E ;MINUTO F
Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults.
2007-01-01 CORNELI G ;DI SOMMA C ;PRODAM F ;BELLONE J ;BELLONE S ;GASCO V ;BALDELLI R ;ROVERE S ;SCHNEIDER HJ ;GARGANTINI L ;GASTALDI R ;GHIZZONI L ;VALLE D ;SALERNO M ;COLAO A ;BONA G ;GHIGO E ;MAGHNIE M ;AIMARETTI G
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience.
2024-01-01 Varaldo E, Sibilla M, Prencipe N, Berton AM, Cuboni D, Aversa LS, Mocellini F, Bioletto F, Ghigo E, Gasco V, Grottoli S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life. | 2024 | Aversa LS, Cuboni D, Grottoli S, Ghigo E, Gasco V. | |
| Acromegalia e gravidanza: quali rischi per la madre e per il feto | 2010 | S. Grottoli, V. Gasco, N. Prencipe, E. Ghigo | |
| Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients | 2020 | Prencipe N.; Scarati M.; Manetta T.; Berton A.M.; Parisi S.; Bona C.; Parasiliti-Caprino M.; Ditto M.C.; Gasco V.; Fusaro E.; Grottoli S. | |
| Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. | 2013 | Gasco V;Beccuti G;Baldini C;Prencipe N;Di Giacomo S;Berton A;Guaraldi F;Tabaro I;Maccario M;Ghigo E;Grottoli S | |
| Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease | 2015 | Gasco V;Berton A;Caprino MP;Karamouzis I;Maccario M;Ghigo E;Grottoli S | |
| Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. | 2023 | Varaldo E, Bioletto F, Cuboni D, Prencipe N, Bona C, Barale M, Ghigo E, Grottoli S, Berton AM, Gasco V. | |
| An overview of the controversies of adult growth hormone deficiency diagnosis. | 2025 | Cuboni D, Aversa LS, Grottoli S, Ghigo E, Gasco V | |
| Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement | 2022 | Cannavò S; Cappa M; Ferone D; Isidori AM; Loche S; Salerno M; Maghnie M; Aimaretti G; Ambrosio MR; Bellone S; Caruso M; Castello R; Ceccato F; Cerbone T; Cherubini V; de Carlo E; De Sanctis L; della Casa S; Di Somma C; Faienza MF; Gasco V; Gaudino R; Giacomozzi C; Giavoli C; Guazzarotti L; Klain A; Lania A; Leonardi D; Longhi S; Lughetti L; Maggio MC; Wasniewska GM; Mameli C; Mauro C; Miraglia Del Giudice E; Palermo MCA; Parpagnoli M; Persani L; Pilotta A; Pozzobon G; Rochira V; Rota F; Sacco M; Scarcella S; Scavuzzo F; Sinisi AA; Street ME; Tornese G | |
| Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? | 2024 | Varaldo E, Cuboni D, Prencipe N, Aversa LS, Sibilla M, Bioletto F, Berton AM, Gasco V, Ghigo E, Grottoli S | |
| Association of craniopharyngioma and pituitary adenoma. | 2013 | Guaraldi F;Prencipe N;di Giacomo V;Scanarini M;Gasco V;Gardiman MP;Berton AM;Ghigo E;Grottoli S | |
| Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study | 2021 | Parasiliti Caprino M, Obert C, Lopez C, Bollati M, Bioletto F, Bima C, Egalini F, Berton AM, Prencipe N, Settanni F, Gasco V, Mengozzi G, Ghigo E, Maccario M. | |
| Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency | 2023 | Gasco V, Giannelli J, Campioni L, Arvat E, Ghigo E, Grottoli S, Maccario M, Giordano R. | |
| Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment | 2021 | Prencipe N.; Bona C.; Cuboni D.; Parasiliti-Caprino M.; Berton A.M.; Fenoglio L.M.; Gasco V.; Ghigo E.; Grottoli S. | |
| Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond | 2024 | Bioletto, Fabio; Varaldo, Emanuele; Gasco, Valentina; Maccario, Mauro; Arvat, Emanuela; Ghigo, Ezio; Grottoli, Silvia | |
| COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM | 2006 | A. Picu; R. Giordano ; L. Bonelli; M. Balbo; M. Pellegrino; R. Berardelli; G. Corneli; V. Gasco; A. Gariano; E. Arvat | |
| Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study | 2023 | Berton, Alessandro Maria; Parasiliti-Caprino, Mirko; Prencipe, Nunzia; Bioletto, Fabio; Lopez, Chiara; Bona, Chiara; Caputo, Marina; Rumbolo, Francesca; Ponzetto, Federico; Settanni, Fabio; Gasco, Valentina; Mengozzi, Giulio; Ghigo, Ezio; Grottoli, Silvia; Maccario, Mauro; Benso, Andrea Silvio | |
| Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma | 2006 | GROTTOLI S; GASCO V; BROGLIO F; BALDELLI R; RAGAZZONI F; GALLENCA F; MAINOLFI A; PRODAM F; MUCCIOLI G; GHIGO E | |
| Cost-of-illness study in acromegalic patients in Italy. | 2004 | DIDONI G ;GROTTOLI S ;GASCO V ;BATTISTINI M ;FERONE D ;GIUSTI M ;RAGAZZONI F ;RUFFO P ;GHIGO E ;MINUTO F | |
| Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. | 2007 | CORNELI G ;DI SOMMA C ;PRODAM F ;BELLONE J ;BELLONE S ;GASCO V ;BALDELLI R ;ROVERE S ;SCHNEIDER HJ ;GARGANTINI L ;GASTALDI R ;GHIZZONI L ;VALLE D ;SALERNO M ;COLAO A ;BONA G ;GHIGO E ;MAGHNIE M ;AIMARETTI G | |
| Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. | 2024 | Varaldo E, Sibilla M, Prencipe N, Berton AM, Cuboni D, Aversa LS, Mocellini F, Bioletto F, Ghigo E, Gasco V, Grottoli S. |